Literature DB >> 33257870

Reply to: What could a new disease activity score for polymyalgia rheumatica do better?

Dario Camellino1,2, Eric L Matteson3, Frank Buttgereit4, Christian Dejaco5,6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33257870     DOI： 10.1038/s41584-020-00551-5

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  What could a new disease activity score for polymyalgia rheumatica do better?

Authors:  Burkhard F Leeb
Journal:  Nat Rev Rheumatol       Date:  2021-03       Impact factor: 20.543

2.  Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review.

Authors:  Helen Twohig; Claire Owen; Sara Muller; Christian D Mallen; Caroline Mitchell; Samantha Hider; Catherine Hill; Beverley Shea; Sarah L Mackie
Journal:  J Rheumatol       Date:  2020-08-01       Impact factor: 4.666
  2 in total
  1 in total

1.  Clinical presentation and treatment response in patients with polymyalgia rheumatica and giant cell arteritis during a 40-week follow-up.

Authors:  Amir Emamifar; Søren Hess; Torkell Ellingsen; Oke Gerke; Ziba Ahangarani Farahani; Per Syrak Hansen; Inger Marie Jensen Hansen; Peter Thye-Rønn
Journal:  Rheumatol Adv Pract       Date:  2021-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.